Ranbaxy resumes supply of Atorvastatin tablets in US

Drug major Ranbaxy Laboratories said on Monday it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market."Ranbaxy Pharmaceuticals Inc, the US......

FDA warns Ranbaxy's American subsidiary

The US Food and Drug Administration has issued a warning letter to Ranbaxy Laboratories' American subsidiary Ohm Laboratories for violating current good manufacturing practice norms. "Ohm......

Ranbaxy launches Lipitor's generic version in US

Drug major Ranbaxy Laboratories has launched its generic version of blockbuster cholesterol-lowering drug Lipitor in the US market.The launch came after final approval from the US health regulator......

Ranbaxy to sell Daiichi Sankyo product in Malaysia

Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo said on Wednesday Ranbaxy will market its parent company's products in Malaysia as part of their initiative to harness synergies between......